Tesamorelin Side Effects

Known side effects

The following side effects have been reported in clinical trials for Tesamorelin:

• Injection site reactions (redness, swelling, bruising, itching) are the most commonly reported adverse effects, occurring in approximately 10-25% of patients in pivotal trials (PMID: 20395564)
• Fluid retention and peripheral edema, particularly in the hands and feet, consistent with GH-class effects from any secretagogue
• Joint pain (arthralgia) and muscle pain (myalgia), dose-related and more common at higher doses or with long-term use
• Potential glucose intolerance: GH elevation decreases insulin sensitivity, and diabetic or pre-diabetic patients require blood glucose monitoring. One Phase 3 trial showed a small but statistically significant increase in fasting glucose in tesamorelin-treated HIV patients (PMID: 20395564)
• Headache, reported in approximately 4-8% of subjects across clinical trials
• Carpal tunnel syndrome-like symptoms (paresthesia, tingling in hands) reported at higher rates than placebo in some trials, consistent with fluid retention and GH-class effects
• Potential cancer risk: elevated IGF-1 has been epidemiologically associated with certain cancers. Tesamorelin is contraindicated in patients with active malignancies. No increased cancer incidence was observed in the pivotal trials, but long-term cancer safety data are limited (PMID: 28400207)
• Loss of efficacy on discontinuation: visceral fat returns to pre-treatment levels within 12 weeks of stopping therapy, requiring ongoing administration to maintain benefits (PMID: 20395564)

Severity and frequency

Clinical trial data provides specific frequency data for Tesamorelin side effects. Most common side effects are mild to moderate and often improve with continued use or dose adjustment.

When to seek medical attention

Contact your healthcare provider immediately if you experience:

• Severe or persistent symptoms that do not improve
• Signs of an allergic reaction (rash, swelling, difficulty breathing)
• Severe abdominal pain
• Changes in vision or neurological symptoms
• Any symptom that concerns you

Risk factors

Side effect risk may be higher in certain populations. Discuss your complete medical history with your doctor, including:

• Pre-existing medical conditions
• Current medications (drug interactions)
• Pregnancy or plans to become pregnant
• History of allergic reactions to peptides or similar compounds

Research references

• Effects of tesamorelin (TH9507), a growth hormone-releasing factor analog, in human immunodeficiency virus-infected patients with excess abdominal fat — Journal of Clinical Endocrinology & Metabolism (2010) [PubMed]
• Effects of growth hormone-releasing hormone on cognitive function in adults with mild cognitive impairment and healthy older adults: results of a controlled trial — Archives of Neurology (2012) [PubMed]
• Tesamorelin effects on muscle morphology and gene expression in HIV-associated lipodystrophy — Journal of the Endocrine Society (2019) [PubMed]
• Prolonged stimulation of growth hormone (GH) and insulin-like growth factor I secretion by CJC-1295, a long-acting analog of GH-releasing hormone, in healthy adults — Journal of Clinical Endocrinology & Metabolism (2006) [PubMed]
• The Safety and Efficacy of Growth Hormone Secretagogues — Sexual Medicine Reviews (2018) [PubMed]